Article
Genome Sequence-Based Discriminator for Vancomycin-Intermediate Staphylococcus aureus
20 Dec 2013
Abstract excerpt
Vancomycin is the mainstay of treatment for patients with Staphylococcus aureus infections, and reduced susceptibility to vancomycin is becoming increasingly common. Accordingly, the development of rapid and accurate assays for the diagnosis of vancomycin-intermediate S. aureus (VISA) will be critical. We developed and applied a genome-based machine-learning approach for discrimination between VISA and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
